New Hampshire 2026 Session Status: Passed Senate 6 R cosponsors

SB 400 — relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.

Last action — House Refuses to Accede to Senate Request for CofC (Rep. Layon): MA VV 05/21/2026 HJ 14 P. 11

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill has passed the Senate. Introduced November 18, 2025. It now moves to the second chamber.

Next likely step: consideration and a floor vote in the House.

Odds of enactment

Moderate chance

Based on the sponsor, cosponsors, and committee posture, this bill has a moderate chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 38% · moderate confidence

  • Passed Senate

    Current position in the legislative process.

  • 8 sponsors

    1 primary, 7 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (6 R).

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

This bill updates reporting requirements for the therapeutic cannabis medical oversight board.

SB 400 requires the therapeutic cannabis medical oversight board to include detailed findings in its annual report regarding medical conditions. It must document reviews and provide scientific citations by January 1 each year.

Summary

relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.

Bill Text

What changed in the latest version

14 added · 14 removed

Plain-language change summary

The revised version of Bill SB 400 changes the frequency with which the Therapeutic Cannabis Medical Oversight Board reviews medical and scientific evidence from annually to every two years. This means the board will now take more time to evaluate the evidence, potentially leading to more comprehensive reviews. Furthermore, the reporting requirement remains the same, ensuring that stakeholders receive annual updates on the findings. This change may allow for a more thorough examination of the evidence without the pressure of yearly deadlines.

→
Previous
Latest
SB 400 - AS AMENDED BY THE HOUSE 01/29/2026 0221s 01/29/2026 0258s 23Apr2026...
SB 400 - AS AMENDED BY THE SENATE 01/29/2026 0221s 01/29/2026 0258s SESSION 26-2041 05/06 SENATE BILL 400 AN ACT relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.
1309h SESSION 26-2041 05/06 SENATE BILL 400 AN ACT relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.
Executive Departments and Administration ───────────────────────────────────────────────────────────────── AMENDED ANALYSIS This bill requires the annual report by the therapeutic cannabis medical oversight board to include documentation of the board's review of currently approved and additional qualifying medical conditions, including the board's findings and recommendations, and citations to the medical and scientific evidence reviewed by the board.
Executive Departments and Administration ───────────────────────────────────────────────────────────────── AMENDED ANALYSIS This bill requires the therapeutic cannabis medical oversight board to biennially review medical and scientific evidence relative to currently approved and additional qualifying conditions.
The bill also requires the board's annual report to include citations to such medical and scientific evidence.
SB 400 - AS AMENDED BY THE HOUSE 01/29/2026 0221s 01/29/2026 0258s 23Apr2026...
SB 400 - AS AMENDED BY THE SENATE 01/29/2026 0221s 01/29/2026 0258s 26-2041 05/06 STATE OF NEW HAMPSHIRE In the Year of Our Lord Two Thousand Twenty-Six AN ACT relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.
1309h 26-2041 05/06 STATE OF NEW HAMPSHIRE In the Year of Our Lord Two Thousand Twenty-Six AN ACT relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.
Duties;
Annual Review of Medical and Scientific Evidence.
Amend RSA 126-X:12, IV(a) to read as follows:
(a) Biennially reviewing medical and scientific evidence pertaining to currently approved and additional qualifying conditions.
Therapeutic Cannabis Medical Oversight Board;
The report shall include documentation of the board's reviews of currently approved and additional qualifying medical conditions, including the board's findings and recommendations, and citations to the medical and scientific evidence reviewed by the board.
The report shall include citations to the medical and scientific evidence reviewed by the board, pertaining to currently approved and additional qualifying conditions.
⬇ Download PDF
View plain text versions (3)

Action History

  1. House Refuses to Accede to Senate Request for CofC (Rep. Layon): MA VV 05/21/2026 HJ 14

  2. President Appoints: Senators Pearl, Gannon, Reardon; (In Recess 04/23/2026); SJ 11

  3. Sen. Pearl Moved Nonconcur with the House Amendment; Requests C of C, MA, VV; (In Recess 04/23/2026); SJ 11

  4. Ought to Pass with Amendment 2026-1309h: MA VV 04/23/2026 HJ 11

  5. Amendment # 2026-1309h: AA VV 04/23/2026 HJ 11

  6. Committee Report: Ought to Pass with Amendment # 2026-1309h 04/08/2026 (Vote 13-1; CC)

  7. Executive Session: 04/08/2026 10:20 am GP 231

  8. Public Hearing: 03/25/2026 10:20 am GP 231

  9. ==CANCELLED== Public Hearing: 03/19/2026 01:30 pm GP 231

  10. Introduced (in recess of) 02/19/2026 and referred to Executive Departments and Administration HJ 5 P. 124

  11. Ought to Pass with Amendments #2026-0221s and #2026-0258s, MA, VV; OT3rdg; 01/29/2026; SJ 2

  12. Sen. Gannon Floor Amendment # 2026-0258s, AA, VV; 01/29/2026; SJ 2

  13. Committee Amendment # 2026-0221s, AA, VV; 01/29/2026; SJ 2

  14. SB 400 was Removed from the Consent Calendar; 01/29/2026; SJ 2

  15. Committee Report: Ought to Pass with Amendment # 2026-0221s, 01/29/2026; Vote 4-0; CC; SC 3

  16. Hearing: 01/21/2026, Room 103, SH, 09:50 am; SC 2

  17. Introduced 01/07/2026 and Referred to Executive Departments and Administration; SJ 1

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 7 co-sponsors · 407 not signed on

Sponsors (1)

Co-sponsors (7)

Not signed on (407)

407 members have not signed on to this bill.

Show all 407 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 400 do?
relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.
Who sponsors SB 400?
SB 400 is sponsored by David Rochefort (Republican), Lilli Walsh (Republican), Liz F Barbour, Howard Pearl (Republican), James L Creighton, Bill Gannon (Republican), Regina Birdsell (Republican), and Michael Vose (Republican).
What is the current status of SB 400?
This bill has passed the Senate. Introduced November 18, 2025. It now moves to the second chamber.
Where can I track SB 400?
Track SB 400 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 400

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 400

Last checked for changes about 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →